AtaiBeckley Inc. is working with advisers to explore options for its flagship psychedelic drug candidate, according to people familiar with the matter.

AtaiBeckley (ATAI) stock is in focus as the company explores strategic options for psychedelic drug BPL-003, seeking a potential $2B+ deal. Read more here.

With his new book On Drugs, Justin Smith-Ruiu explores these powerful drugs through a philosophical lens, analyzing their ...

While drug-induced mystical experiences can have benefits, research suggests they may not be enough to create lasting change.

Veterans and others who have suffered trauma and injuries are flocking to clinics around the world to take ibogaine. My own ...

(The Center Square) - State leaders across the country are pushing for medical trials of the psychedelic drug ibogaine to treat neurological conditions. Former Texas Gov. Rick Perry spoke at the ...

A new study in Communications Biology provides evidence that a psychedelic drug induces a hybrid sleep-wake state in active mice. This unusual brain activity suggests a potential mechanism for how ...

Add Yahoo as a preferred source to see more of our stories on Google. People who think psychedelic drugs are the key to treating intractable mental illness could not have been more psyched when Donald ...

A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive ...

Maryland residents may someday be able to legally use certain natural psychedelic drugs if the legislature takes action on a report delivered this week. The Task Force on Responsible Use of Natural ...